TSTimoteo Solano-Armas

Timoteo Solano-Armas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Timoteo Solano-Armas has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Leakage-Aware Evaluation of Ensemble Classifiers for Symptom-Based Classification of Diabetes Status: Performance, Calibration, and Explainability

    by Daniel Andrade-Girón, William Marin-Rodriguez, Americo Peña, Enrique Diaz-Vega, Abrahán Neri-Ayala, Viviana Vellon-Flores, Timoteo Solano-Armas, Algemiro Muñoz-Vilela

    Background/Objectives: Diabetes impose a substantial public health burden. Machine learning models trained on symptom data may help identify individuals whose recorded symptom profiles warrant confirmatory clinical assessment. This study compared ten en-semble models for symptom-based classification of a dataset-provided diabetes-status la-bel. Methods: The UCI Early-Stage Diabetes Risk Prediction Dataset was used, comprising 520 observations, 251 unique predictor profiles, 16 predictors, and a binary positive/negative diabetes-status label. All observations were retained, while identical predictor profiles were kept within the same partition during data splitting, nested cross-validation, hy-perparameter optimization, and calibration to reduce information leakage. The weighted F1-score was the optimization objective and primary model-selection metric throughout the analysis. Results: Bagging Extra Tree achieved the highest observed mean weighted F1-score (94.07% ± 7.99%) and MCC (0.876 ± 0.167) and was selected as the final model under the prespecified criterion. An exploratory Friedman analysis indicated variation in model rankings across folds (p = 0.001859), although no Nemenyi-adjusted pairwise comparison reached the nominal significance level. On the profile-disjoint internal holdout set, the calibrated model achieved a weighted F1-score of 0.9224, an MCC of 0.8207, a ROC-AUC of 0.9844, and a Brier score of 0.0528. Random Forest was selected in the unique-profile sensitivity analysis but yielded lower holdout performance, indicating sensitivity to the analytical unit. Conclusions: These findings provide internal evidence that tree-based ensembles can clas-sify the dataset-provided diabetes-status label under profile-disjoint evaluation. They do not establish prospective risk prediction or clinical diagnostic utility; independent exter-nal validation is required before clinical implementation.

  • Open Access

    Comparative Evaluation of Ensembles in Type 2 Diabetes Classification: Performance, Explainability, and Interpretability

    by Daniel Andrade-Girón, William Marin-Rodriguez, Americo Peña, Enrique Diaz-Vega, Viviana Vellon-Flores, Timoteo Solano-Armas, Algemiro Muñoz-Vilela

    Type 2 diabetes mellitus (T2DM) is a priority public health issue that requires accurate, efficient, and interpretable predictive tools to support the early identification of at-risk cases. Nevertheless, the comparison of machine learning models in this domain is frequently constrained by heterogeneous protocols, a reliance on overall accuracy, and an inadequate integration of metrics for agreement, calibration, robustness, and interpretability. This study employed a comparative approach to evaluate 10 ensemble and boosting models for the binary classification of T2DM under a unified experimental protocol. The evaluation employed nested cross-validation with 10 external folds and 3 internal folds, a 20% internal holdout, and complementary metrics of performance, discrimination, agreement, calibration, and computational cost. In the context of nested cross-validation, the Random Forest algorithm demonstrated a superior performance, attaining the highest average weighted F1-score (92.51 ± 5.80%), the highest Matthews' correlation coefficient (MCC) (0.840 ± 0.120%), and high discriminative power (weighted area under the receiver operating characteristic curve (ROC-AUC) = 97.46 ± 2.12%). Consequently, it was selected based on a predefined composite criterion. CatBoost achieved the highest weighted ROC-AUC (97.91 ± 2.39%) and area under the precision-recall curve (PR-AUC) (96.60 ± 3.61%), while Extra Trees demonstrated performance that was virtually equivalent to that of the selected model. The Friedman test revealed significant overall differences among models (χ² = 27.898607; p = 0.000992). However, the Nemenyi post-hoc test indicated that the leading models were statistically comparable to one another and that the significant differences were concentrated relative to AdaBoost. In the holdout set, the calibrated Random Forest attained an accuracy of 0.882, a balanced accuracy of 0.880, a weighted F1-score of 0.884, an ROC-AUC of 0.943, a PR-AUC of 0.879, a κ of 0.736, an MCC of 0.739, a Brier score of 0.091, and an expected calibration error of 0.130, with a recall of 0.88 for the positive class. Explainability analyses employing SHapley Additive Explanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME) techniques have been demonstrated to offer traceability and predictive plausibility, whilst eschewing the assumption of causality. The findings of this study suggest that Random Forest, Extra Trees, and CatBoost represent robust alternatives for the tabular classification of T2DM. However, it is important to note that their clinical application requires multicenter external validation, local recalibration, and prospective evaluation.